Hyperglycemia in pediatric age: could it be maturity onset diabetes of the young? Case reports and review of the literature
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Maturity Onset Diabetes of the Young (MODY) includes a clinically and genetically heterogeneous group of diabetes subtypes with MODY-2 being the second most prevalent form. We report 2 cases of MODY-2 identified during the investigation of asymptomatic hyperglycemia. A 12-year-old girl with a familiar history of diabetes (mother, maternal aunt, and maternal grandfather) was referred due to hypercholesterolemia, abnormal fasting glucose (114 mg/dL), and increased levels of glycated haemoglobin (HbA1c) (6%) presenting with negative β-cell antibodies. A glucokinase (GCK) heterozygous missense mutation c.364C>T (p.Leu122Phe) in exon 4 was identified in the index patient and in the 3 family members. An obese 9-year-old boy was investigated for elevated fasting glycemic levels (99–126 mg/dL), HbA1c rise (6.6%–7.6%), and negative β-cell antibodies. The patient’s father, paternal aunt, and paternal grandfather had a history of diabetes during their childhood. A GCK heterozygous missense mutation c.698G>A (p.Cys233Tyr) in exon 7 was identified in the index patient. This variant was only described in another family strongly affected by both MODY and classic autoimmune mediated diabetes, contrary to our case. MODY-2 should be suspected in the presence of early onset of persistent mild fasting hyperglycemia and negative β-cell antibodies associated with a positive family history of diabetes. These cases illustrate the challenging aspects of MODY diagnosis due to possible phenotypic overlap with other types of diabetes. The diagnosis requires a high level of suspicion and GCK genetic screening should be performed in the presence of compatible features. An early diagnosis allows for appropriate management, genetic counselling, and the identification of affected family members.
Abstract
Maturity Onset Diabetes of the Young (MODY) includes a clinically and genetically heterogeneous group of diabetes subtypes with MODY-2 being the second most prevalent form. We report 2 cases of MODY-2 identified during the investigation of asymptomatic hyperglycemia. A 12-year-old girl with a familiar history of diabetes (mother, maternal aunt, and maternal grandfather) was referred due to hypercholesterolemia, abnormal fasting glucose (114 mg/dL), and increased levels of glycated haemoglobin (HbA1c) (6%) presenting with negative β-cell antibodies. A glucokinase (GCK) heterozygous missense mutation c.364C>T (p.Leu122Phe) in exon 4 was identified in the index patient and in the 3 family members. An obese 9-year-old boy was investigated for elevated fasting glycemic levels (99–126 mg/dL), HbA1c rise (6.6%–7.6%), and negative β-cell antibodies. The patient’s father, paternal aunt, and paternal grandfather had a history of diabetes during their childhood. A GCK heterozygous missense mutation c.698G>A (p.Cys233Tyr) in exon 7 was identified in the index patient. This variant was only described in another family strongly affected by both MODY and classic autoimmune mediated diabetes, contrary to our case. MODY-2 should be suspected in the presence of early onset of persistent mild fasting hyperglycemia and negative β-cell antibodies associated with a positive family history of diabetes. These cases illustrate the challenging aspects of MODY diagnosis due to possible phenotypic overlap with other types of diabetes. The diagnosis requires a high level of suspicion and GCK genetic screening should be performed in the presence of compatible features. An early diagnosis allows for appropriate management, genetic counselling, and the identification of affected family members.
참고문헌 (20)
- Codner E, "Glucokinase mutations in young children with hyperglycemia", Diabetes Metab Res Rev, 22, pp.348~355 (2006)
- Amed S, "Maturity-Onset Diabetes of the Young (MODY): making the right diagnosis to optimize treatment", Can J Diabetes, 40, pp.449~454 (2016)
- Ellard S, "Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young", Diabetologia, 51, pp.546~553 (2008)
- Gardner DS, "Clinical features and treatment of maturity onset diabetes of the young (MODY)", Diabetes Metab Syndr Obes, 5, pp.101~108 (2012)
- Wheeler BJ, "Frequency and genetic spectrum of maturity-onset diabetes of the young (MODY) in southern New Zealand", J Diabetes Metab Disord, 12, pp.46~ (2013)
- Caetano LA, "Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects", Arq Bras Endocrinol Metabol, 56, pp.519~524 (2012)
- Bonfig W, "GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation", ISRN Pediatr, 2011, pp.676549~ (2011)
- Schwitzgebel VM, "Many faces of monogenic diabetes", J Diabetes Investig, 5, pp.121~133 (2014)
- Kevin Colclough, "Clinical utility gene card for: Maturity-onset diabetes of the young", European Journal of Human Genetics, 22(9), pp.1153~1153 (2014), Springer Science and Business Media LLC[DOI]
- Timsit J, "Searching for Maturity-Onset Diabetes of the Young (MODY): when and what for?", Can J Diabetes, 40, pp.455~461 (2016)
- Giuffrida FMA, "Maturity-onset diabetes of the young (MODY) in Brazil: establishment of a national registry and appraisal of available genetic and clinical data", Diabetes Res Clin Pract, 123, pp.134~142 (2017)
- Pinelli M, "Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2)gene testing: a seven-item clinical flowchart (7-iF)", PLoS One, 8, pp.e79933~ (2013)
- Kavvoura FK, "Maturity onset diabetes of the young: clinical characteristics, diagnosis and management", Pediatr Endocrinol Rev, 10, pp.234~242 (2012)
- "An Online Catalog of Human Genes and Genetic Disorders. MIM Number: 125851" (2012)[URL]
- Wędrychowicz A, "Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCKMODY)patients", J Clin Res Pediatr Endocrinol, 9, pp.246~252 (2017)
- Steele AM, "Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia", JAMA, 311, pp.279~286 (2014)
- Osbak KK, "Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia", Hum Mutat, 30, pp.1512~1526 (2009)
- "The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff" (2017)[URL]
- "VarSome"[URL]
- "ClinVar"[URL]